首页> 外文OA文献 >The efficacy of darbepoetin alfa for treating anemia, when administered intravenously once weekly: Hemodialysis patients (n=157) maintained on recombinant human erythropoietin were switched to darbepoetin alfa

【2h】

The efficacy of darbepoetin alfa for treating anemia, when administered intravenously once weekly: Hemodialysis patients (n=157) maintained on recombinant human erythropoietin were switched to darbepoetin alfa

机译：当每周一次静脉内施用时，Darbopoetin Alfa治疗贫血的疗效：将重组人促红细胞生成素维持的血液透析患者（n = 157）切换到Darbepoetin Alfa

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Yasuji Kuroda; Takashi Okumura; Hiroya Takeoka; Keisuke Nishioka; Susumu Oseto; Norikazu Kanemitsu; Megumu Fukunaga;
展开▼
作者单位

展开▼
年度 2008
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Randomized equivalence study evaluating the possibility of switching hemodialysis patients receiving subcutaneous human erythropoietin directly to intravenous darbepoetin alfa. [J] . Chazot C, Terrat JC, Dumoulin A, The annals of pharmacotherapy . 2009,第2期

机译：随机等价研究评估了将接受血液透析的皮下人促红细胞生成素的患者直接换用静脉注射达比泊汀阿尔法的可能性。
2. Darbepoetin alfa effectively maintains haemoglobin concentrations at extended dose intervals relative to intravenous or subcutaneous recombinant human erythropoietin in dialysis patients. [J] . Brunkhorst R, Bommer J, Braun J, Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association . 2004,第5期

机译：相对于透析患者的静脉内或皮下重组人促红细胞生成素，达比泊汀α有效地维持延长剂量间隔的血红蛋白浓度。
3. Intravenously administered darbepoetin alfa once a week could maintain hemoglobin level more efficiently than once every 2 weeks in patients on hemodialysis [J] . NagayaH., InagumaD., KitagawaA., Clinical and experimental nephrology . 2010,第2期

机译：血液透析患者每周一次静脉注射达比泊汀α可以比每两周一次更有效地维持血红蛋白水平
4. Iron and ferritin status in hemodialysis patients under darbepoetin alfa therapy [C] . Tokmak, F., Kisters, Workshop on Macro, Trace and Ultratrace Elements; 20040924-25; Jena(DE) . 2004

机译：达贝泊汀α疗法对血液透析患者铁和铁蛋白的影响
5. Understanding off-label utilization patterns of two biotechnology drugs, recombinant erythropoietin alfa and darbepoetin alfa: A multi-hospital study. [D] . Patkar, Anuprita D. 2005

机译：了解两种生物技术药物的标签外利用模式：重组促红细胞生成素α和darbepoetin alfa：一项多院研究。
6. Unit dosing of darbepoetin alfa for thetreatment of anemia in patients with end-stage renal disease being switched from recombinant human erythropoietin: Results of a phase IIIb 27-week multicenter open-label study in Greek patients [O] . Georgios Bristoyiannis, Nikolaos Germanos, Dimitrios Grekas, 2005

机译：从重组人促红细胞生成素转换为晚期肾病患者贫血治疗中达比泊汀α的单位剂量：一项针对希腊患者的27b周多中心开放性研究的IIIb期研究结果
7. Unit dosing of darbepoetin alfa for thetreatment of anemia in patients with end-stage renal disease being switched from recombinant human erythropoietin: Results of a phase IIIb, 27-week, multicenter, open-label study in Greek patients [O] . Bristoyiannis Georgios, Germanos Nikolaos, Grekas Dimitrios, 2005

机译：从重组人类促红细胞生成素转换为晚期肾病患者贫血治疗中达比泊汀α的单位剂量：一项针对希腊患者的27b周，多中心，IIIb期临床研究的结果

The efficacy of darbepoetin alfa for treating anemia, when administered intravenously once weekly: Hemodialysis patients (n=157) maintained on recombinant human erythropoietin were switched to darbepoetin alfa

著录项

相似文献

相关主题

期刊订阅